Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Virus Lower Respiratory Tract Infection”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Testing effectiveness (Phase 2)Study completedNCT02979431
What this trial is testing

Dose Ranging Study of ALX-0171 in Infants Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection

Who this might be right for
Respiratory Syncytial Virus Lower Respiratory Tract Infection
Ablynx, a Sanofi company 180
Not applicableStudy completedNCT01090557
What this trial is testing

Exhaled Nitric Oxide in Respiratory Syncytial Virus (RSV) Bronchiolitis: a Pilot Study

Who this might be right for
RSV InfectionBronchiolitis
Winthrop University Hospital 60
Not applicableStudy completedNCT01995175
What this trial is testing

A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age

Who this might be right for
Respiratory Syncytial Virus
GlaxoSmithKline 2,409
Testing effectiveness (Phase 2)Ended earlyNCT04225897
What this trial is testing

Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection.

Who this might be right for
Respiratory Syncytial Virus (RSV)Lower Resp Tract Infection
Pfizer 51
Testing effectiveness (Phase 2)Study completedNCT01502072
What this trial is testing

Respiratory Syncytial Virus - RSV Protocol

Who this might be right for
Bone Marrow Transplant InfectionInfection in Marrow Transplant RecipientsRespiratory Syncytial Virus Infections+3 more
M.D. Anderson Cancer Center 48
Not applicableActive Not RecruitingNCT06077968
What this trial is testing

Learn About ABRYSVO Vaccine in Older Adults to Prevent Severe Respiratory Syncytial Virus (RSV) Disease

Who this might be right for
Respiratory Syncytial Viruses
Pfizer 1
Large-scale testing (Phase 3)Study completedNCT06614725
What this trial is testing

A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD)

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 751
Not applicableNot Yet RecruitingNCT07015255
What this trial is testing

Assessing the Burden of Respiratory Syncytial Virus (RSV)

Who this might be right for
Respiratory Syncytial Virus (RSV) InfectionAcute Lower Respiratory Tract InfectionsBronchiolitis+2 more
Abu Dhabi Health Services Company 1,500
Large-scale testing (Phase 3)Study completedNCT03979313
What this trial is testing

Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Healthy Late Preterm and Term Infants (MELODY)

Who this might be right for
Respiratory Syncytial Virus Infections
AstraZeneca 3,012
Not applicableStudy completedNCT00435994
What this trial is testing

Assessment of Airway Obstruction in Infants With Lower Respiratory Infections

Who this might be right for
BronchiolitisRespiratory Syncytial Virus Infections
Indiana University School of Medicine 59
Early research (Phase 1)Active Not RecruitingNCT06904222
What this trial is testing

Safety and Immunogenicity of the Recombinant Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 18 Years and Older

Who this might be right for
Respiratory Syncytial Virus Infection
Guangzhou Patronus Biotech Co., Ltd. 90
Post-approval studies (Phase 4)Not Yet RecruitingNCT06955728
What this trial is testing

A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection When the Pregnant Woman Receives the Approved RSV Vaccine Compared to a Placebo.

Who this might be right for
RSV InfectionsRSV ImmunisationPreterm Labour
University of Witwatersrand, South Africa 13,000
Testing effectiveness (Phase 2)Looking for participantsNCT06665100
What this trial is testing

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

Who this might be right for
Hematologic MalignanciesHematopoietic Stem Cell Transplant (HSCT)
Pulmotect, Inc. 100
Large-scale testing (Phase 3)Active Not RecruitingNCT05110261
What this trial is testing

Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in China

Who this might be right for
Lower Respiratory Tract Infection
AstraZeneca 800
Testing effectiveness (Phase 2)Looking for participantsNCT07214571
What this trial is testing

S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease

Who this might be right for
Respiratory Syncytial Virus Infections
Shionogi 192
Early research (Phase 1)Study completedNCT05281263
What this trial is testing

Phase 1 Study of BLB-201 Vaccine in Healthy Young and Older Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Blue Lake Biotechnology Inc. 30
Testing effectiveness (Phase 2)WithdrawnNCT03468829
What this trial is testing

Efficacy and Safety of ALX-0171 in Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients Who Present With Respiratory Syncytial Virus (RSV) Infection

Who this might be right for
Respiratory Syncytial Virus Lower Respiratory Tract Infection
Ablynx, a Sanofi company
Early research (Phase 1)Study completedNCT00345670
What this trial is testing

Study to Evaluate the Safety of MEDI-534 Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in Healthy Children

Who this might be right for
Healthy
MedImmune LLC 120
Large-scale testing (Phase 3)Study completedNCT05590403
What this trial is testing

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 50-59 Years of Age, Including Adults at Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease, Compared to Older Adults 60 Years of Age and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,544
Not applicableActive Not RecruitingNCT07249320
What this trial is testing

Evaluating ABRYSVO Maternal Vaccine Effectiveness Among Infants

Who this might be right for
Respiratory Syncytial Virus (RSV)
Pfizer 39,456
Load More Results